Page last updated: 2024-09-05

glucose tetrasaccharide and Acid Alpha-Glucosidase Deficiency

glucose tetrasaccharide has been researched along with Acid Alpha-Glucosidase Deficiency in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (8.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (33.33)	29.6817
2010's	6 (50.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
de Boer, F; Derks, TGJ; Fokkert-Wilts, MJ; Heiner-Fokkema, MR; Hoogeveen, IJ; Maatman, RGHJ; van der Krogt, J	1
Bobillo Lobato, J; Durán Parejo, P; Jiménez Jiménez, LM; Tejero Díez, P	1
Ahmadipour, F; Aryani, O; Fani, S; Houshmand, M; Kamalidehghan, B; Khalili, E; Manshadi, MD; Tondar, M	1
Bali, D; Corzo, D; Kishnani, PS; Millington, DS; Thurberg, BL; Young, SP; Zhang, H	1
Bainbridge, K; Burke, D; Finnegan, N; Franses, R; Heales, S; Lam, A; Manwaring, V; Prunty, H; Vellodi, A	1
Bali, D; Case, LE; Champion, M; Dimmock, D; Hershkovitz, E; Jones, SA; Kishnani, PS; Mendelsohn, NJ; Messinger, YH; Olson, R; Rhead, W; Rosenberg, AS; Wells, C; White, A; Young, SP	1
Bali, DS; Bashir, MR; Goldstein, JL; Kishnani, PS; Laforet, P; Millington, DS; Piraud, M; Rehder, C; Young, SP; Zhang, H	1
Higuchi, I; Kawano, Y; Maegaki, Y; Maruyama, S; Nanba, E; Narita, A; Ohno, K; Toyoshima, M; Yonee, C; Young, SP	1
An, Y; Chen, YT; Millington, DS; Stevens, RD; Young, SP	1
Amalfitano, A; An, Y; Chen, YT; Corz, D; Kishnani, PS; Millington, DS; Young, SP	1
Chester, MA; Häger, A; Loonen, C; Lundblad, A; Sjöblad, S; Tager, JM; Zopf, D	1
An, Y; Chen, YT; Hillman, SL; Millington, DS; Van Hove, JL; Young, SP	1

Trials

2 trial(s) available for glucose tetrasaccharide and Acid Alpha-Glucosidase Deficiency

Article	Year
[Tetra-saccharide glucose as a diagnostic biomarker for Pompe disease: a study with 35 patients]. Medicina clinica, 2013, Aug-04, Volume: 141, Issue:3 Topics: Adolescent; Adult; Age of Onset; Area Under Curve; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides; ROC Curve; Young Adult	2013
Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genetics in medicine : official journal of the American College of Medical Genetics, 2009, Volume: 11, Issue:7 Topics: Alanine Transaminase; alpha-Glucosidases; Aspartate Aminotransferases; Biomarkers; Creatine Kinase; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Monitoring, Physiologic; Muscle, Skeletal; Oligosaccharides; Tandem Mass Spectrometry	2009

Article

Year

[Tetra-saccharide glucose as a diagnostic biomarker for Pompe disease: a study with 35 patients].

Medicina clinica, 2013, Aug-04, Volume: 141, Issue:3

Topics: Adolescent; Adult; Age of Onset; Area Under Curve; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides; ROC Curve; Young Adult

2013

Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.

Genetics in medicine : official journal of the American College of Medical Genetics, 2009, Volume: 11, Issue:7

Topics: Alanine Transaminase; alpha-Glucosidases; Aspartate Aminotransferases; Biomarkers; Creatine Kinase; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Monitoring, Physiologic; Muscle, Skeletal; Oligosaccharides; Tandem Mass Spectrometry

2009

Other Studies

10 other study(ies) available for glucose tetrasaccharide and Acid Alpha-Glucosidase Deficiency

Article	Year
The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases. Genetics in medicine : official journal of the American College of Medical Genetics, 2020, Volume: 22, Issue:11 Topics: Biomarkers; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Liver; Oligosaccharides	2020
A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease). Molecular biology reports, 2014, Volume: 41, Issue:9 Topics: alpha-Glucosidases; Cardiomyopathies; Consanguinity; Exons; Genetic Predisposition to Disease; Genome-Wide Association Study; Genome, Human; Genotype; Genotyping Techniques; Glucan 1,4-alpha-Glucosidase; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Iran; Male; Mutation; Oligosaccharides; Sequence Analysis, DNA	2014
Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases. Journal of inherited metabolic disease, 2012, Volume: 35, Issue:2 Topics: Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Enzyme Replacement Therapy; Female; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides	2012
Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. Genetics in medicine : official journal of the American College of Medical Genetics, 2012, Volume: 14, Issue:1 Topics: alpha-Glucosidases; Antibodies; B-Lymphocytes; Enzyme Replacement Therapy; Female; Glycogen Storage Disease Type II; Humans; Immune Tolerance; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Neuroimaging; Oligosaccharides; Recombinant Proteins; Treatment Outcome	2012
Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques. American journal of medical genetics. Part C, Seminars in medical genetics, 2012, Feb-15, Volume: 160C, Issue:1 Topics: Adult; Age Factors; Aged; alpha-Glucosidases; Biomarkers; Child; Child, Preschool; Diagnostic Imaging; Disease Progression; Enzyme Replacement Therapy; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Middle Aged; Muscle, Skeletal; Mutation; Oligosaccharides; Prognosis; Sequence Analysis, DNA; Treatment Outcome; Young Adult	2012
Quantitative computed tomography for enzyme replacement therapy in Pompe disease. Brain & development, 2012, Volume: 34, Issue:10 Topics: alpha-Glucosidases; Child, Preschool; Enzyme Replacement Therapy; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Liver; Muscle, Skeletal; Oligosaccharides; Tomography, X-Ray Computed	2012
Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry. Analytical biochemistry, 2003, May-15, Volume: 316, Issue:2 Topics: Biomarkers; Calibration; Carbohydrate Sequence; Carbon Isotopes; Chromatography, High Pressure Liquid; Glycogen Storage Disease Type II; Humans; Indicator Dilution Techniques; Molecular Sequence Data; Oligosaccharides; Reference Standards; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization	2003
Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. Molecular genetics and metabolism, 2005, Volume: 85, Issue:4 Topics: alpha-Amylases; alpha-Glucosidases; Biomarkers; Case-Control Studies; Glucan 1,4-alpha-Glucosidase; Glycogen; Glycogen Storage Disease Type II; Humans; Monitoring, Physiologic; Oligosaccharides	2005
Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III. Lancet (London, England), 1983, Apr-30, Volume: 1, Issue:8331 Topics: Adult; Aged; Child; Child, Preschool; Female; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Heterozygote; Humans; Male; Middle Aged; Oligosaccharides	1983
Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Analytical biochemistry, 2000, Dec-01, Volume: 287, Issue:1 Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides; Sensitivity and Specificity	2000